Aims and Scope:
The first type of manuscripts consists of sets of papers providing an in-depth expression of the current state of the art in various rapidly developing components of world transplantation biology and medicine. These manuscripts emanate from congresses of the affiliated transplantation societies, from Symposia sponsored by the Societies, as well as special Conferences and Workshops covering related topics.
Transplantation Research is a peer-reviewed, open access, online journal that publishes articles on a broad range of topics in the discipline of transplantation. The content of this journal is directed towards both basic scientists and clinicians in this field, with the aim of informing all transplantation researchers and those interested in transplantation. Among the research topics included in Transplantation Research are: organ preservation ischemia-reperfusion injury and inflammation histocompatibility pharmacological/experimental immunosuppression immune recognition - regulation, and tolerance induction strategies stem cell research for tissue regeneration/repair and immune regulation early-stage clinical trials and clinical trial protocols innovative method protocols complications of transplantation, including graft dysfunction, tissue repair, infections and posttransplant malignancy biomarker investigation organ donation and other ethical issues xenotransplantation. Types of transplantation primarily included are thoracic (heart and lung), abdominal (kidney, liver and pancreas) and tissue (islets, composite tissue). Transplantation Research emphasizes the publication of experimental research and pilot clinical trials that introduce new ideas and concepts to the field of transplantation.Transplantation Research is a forum for the quick release of cutting-edge experimental and clinical research in transplantation. Introduction of novel experimental concepts and early stage trial results are welcomed for publication and debate. As an open access online journal, Transplantation Research is in an optimal position to publish data and ideas with the least delay and with the greatest, exposure due to lack of restrictions regarding access. This represents a major new platform for transplantation researchers.
Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our
Please see our
medline.jpg
For more information, go to http://www.cell.com/trends/immunology
Trials in Vaccinology is a new peer-reviewed online-only journal that will guarantee direct public access to the results of vaccine trials in humans and target animals, especially those of whose scientific novelty is not exceptional, and thus increase the transparency of current supportive scientific research in the field of vaccines. It will also provide opportunities for those engaged in these trials to gain recognition for their work and for those who use or comment on the value of vaccines to gain additional evidence to further hone their understandings.The objective of this journal is to be inclusive and supportive, and not to select only those trials that make innovative contributions to the field of vaccinology; these latter papers will find their home in the journal "Vaccine"http://www.elsevier.com/locate/vaccineTrials in Vaccinology will provide a facility that will enable both vaccinologists and those interested in the use of vaccines to gain insights and understandings of the breadth and depth of evidence that is available for the appreciation of the properties of a vaccine and its place in the healthcare and animal husbandry systems that are used in different countries and with particular cohorts of vaccinees.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Tuberculosis is a speciality journal focusing on basic experimental research on tuberculosis, notably on bacteriological, immunological and pathogenesis aspects of the disease. The journal publishes original research and reviews on the host response and immunology of tuberculosis and the molecular biology, genetics and physiology of the organism.Areas covered include:ImmunologyImmunogeneticsPathogeneticsMicrobiologyMicrobial physiologyPathogenesisPathologyMolecular epidemiologyDiagnosticsVaccine developmentDrug resistanceThe resurgence of interest in tuberculosis has accelerated the pace of relevant research and Tuberculosis has grown with it, as the only journal dedicated to experimental biomedical research in tuberculosis.To view the benefits of Online Submission please click here.
Vaccine is the journal for those interested in vaccines and vaccination. Submissions to the following categories are welcomed: Human Vaccines - infectious diseases; Human Vaccines - non-infectious diseases; Veterinary Vaccines; Immunology and Animal Models; Vectors, Adjuvants and Delivery Systems; Production, manufacturing; Vaccine Safety; Regulatory, Societal and Legislation Aspects; History of Vaccinology.
Vaccines (ISSN 2076-393X) is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Vaccines publishes high quality reviews, regular research papers, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in open access form in as much detail as possible. The full experimental details must be provided so that the results can be reproduced. There are, in addition, unique features of this journal: manuscripts regarding research proposals and research ideas will be particularly welcomed computed data or files regarding the full details of the experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material we also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds
Sin duda una de las mejores publicaciones para conocer los avances en el campo de las vacunaciones preventivas, tanto en el ámbito de la investigación básica como aplicada y en la evaluación de programas de vacunaciones. Su alta calidad y utilidad la ha llevado a estar indexada en los prestigiosos índices IME y SCOPUS.4 NÚMEROS AL AÑOPara más información, consulte http://www.elsevier.es/vac
The journal reports basic, comparative and clinical immunology as they pertain to the animal species designated here: livestock, poultry, and fish species that are major food animals and companion animals such as cats, dogs, horses and camels, and wildlife species that act as reservoirs for food, companion or human infectious diseases, or as models for human disease.Rodent models of infectious diseases that are of importance in the animal species indicated above,when the disease requires a level of containment that is not readily available for larger animal experimentation (ABSL3), will be considered. Papers on rabbits, lizards, guinea pigs, badgers, armadillos, elephants, antelope, and buffalo will be reviewed if the research advances our fundamental understanding of immunology, or if they act as a reservoir of infectious disease for the primary animal species designated above, or for humans. Manuscripts employing other species will be reviewed if justified as fitting into the categories above.The following topics are appropriate: biology of cells and mechanisms of the immune system, immunochemistry, immunodeficiencies, immunodiagnosis, immunogenetics, immunopathology, immunology of infectious disease and tumors, immunoprophylaxis including vaccine development and delivery, immunological aspects of pregnancy including passive immunity, autoimmuity, neuroimmunology, and transplanatation immunology. Manuscripts that describe new genes and development of tools such as monoclonal antibodies are also of interest when part of a larger biological study. Studies employing extracts or constituents (plant extracts, feed additives or microbiome) must be sufficiently defined to be reproduced in other laboratories and also provide evidence for possible mechanisms and not simply show an effect on the immune system.Ideas and suggestions for Special Issues are also welcome. These may focus on a planned conference/symposium for which a selection of the best papers could be published together (after peer review). Alternatively, they could consist of a group of invited papers which together present an up-to-date overview on an important immunological topic.
Viral Immunology is a peer-reviewed journal centralizing on the growing body of research in viral immunology, with papers on clinical, veterinary, and laboratory research. This journal is essential for virologists, immunologists, microbiologists, infectious disease specialists, research and development scientists, epidemiologists, veterinary researchers, and other professionals who need to be kept up to date on all aspects of viral immunology. Topics covered include: • Human and animal viral immunology • Research and development of viral vaccines, including field trials • Immunological characterization of viral components • Virus-based immunological diseases, including autoimmune syndromes • Pathogenic mechanisms • Viral diagnostics • Tumor and cancer immunology with virus as the primary factor • Viral immunology methods .
The World Allergy Organization Journal (WAO Journal) (www.WAOJournal.org) provides a dynamic platform for the exchange of perspectives and knowledge among researchers and practitioners from all regions of the world. It is the official publication of the highly regarded World Allergy Organization, the only global umbrella organization for national and regional allergology and clinical immunology societies. The WAO Journal offers readers information that is extending our understanding of pathogenesis and disease function, and new approaches for evaluation of allergic disease and outcomes concerning treatments and interventions. Encompassing both translational research and clinical issues, the WAO Journal is dedicated to providing compelling articles and up-to-date science for readers, and faster publication and worldwide recognition for contributors. Individual and In-Training subscribers receive fully searchable online access to articles from Volume 1 to the present at www.WAOJournal.org8212;now available on a powerful new website! This best-in-class website platform uses Web 2.0 functionality to provide an enhanced online experience through such features as: saved searches, personal article collections, easy image downloads to PowerPoint, and more.Individual subscribers: Please contact LWW Customer Service (1-800-638-3030) to order this online journal.Institutional subscribers: Online subscriptions are available via Ovid. For more information and to request pricing for an online journal subscription, please contact the Regional Ovid Sales Office closest to you.Members of current WAO Member Societies receive free access to the World Allergy Organization Journal. Go to www.WorldAllergy.org. Click Members Only then WAO Journal.
Xenotransplantation, which is published bi-monthly, provides its readers with rapid communication of new findings in the field of organ and tissue transplantation across species barriers with the goal of clinical xenotransplantation (for the purpose of clinical application). Unsolicited contributions of full length and brief communications dealing with both basic and applied studies in this field will be considered for publication pending scientific review to assure high quality. In addition, review articles of timely subjects will be solicited by the editors. Xenotransplantation is the journal for all those who wish to stay at the forefront of this fast developing and emerging field.